NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has closed its offering of senior notes, raising $2.2 billion.
As reported last week, the firm offered $300 million aggregate principal amount of 2.05 percent senior notes due 2014; $900 million aggregate principal amount of 3.2 percent senior notes due 2016; and $1 billion aggregate principal amount of 4.5 percent senior notes due 2021.
The firm said in a filing today with the US Securities and Exchange Commission that the 2014 notes will mature on Feb. 21, 2014, the 2016 notes will mature on March 1, 2016, and the 2021 notes will mature on March 1, 2021.
Thermo Fisher will use the proceeds to pay for its $2.1 billion acquisition of Dionex, which was announced in December. Last week, the firm said that it had extended its tender offer to acquire all of the outstanding shares of Dionex for $118.50 per share until midnight, New York City time, on April 7.